H.R. 4365/S. 2587 - Department of Defense Appropriations for FY 2024; H.R. 2882 - Further Consolidated Appropriations Act, 2024 and unnumbered House and Senate FY25 Department of Defense Appropriations - issues related to defense technology.
Issues related to implementation of the Chips and Science Act of 2022 (P.L. 117-167).
Duration: February 3, 2020
to
present
General Issues: Budget/Appropriations , Defense , Health Issues , Medical/Disease Research/Clinical Labs
Spending: about $990,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2020: House of Representatives, U.S. Senate, Defense - Dept of (DOD), Health & Human Services - Dept of (HHS), Office of Science & Technology Policy (OSTP)
Affiliated organizations: Qorvo
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Anne LeMay
LA/Dir of Def & For Affairs, Rep McHugh; Prof Staff, House Armed Services Comm; Spec Asst/CoS to Secretary of Army
John McHugh
U.S. Congressman; Secretary of the U. S. Army
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, MCHUGH LEMAY ASSOC., LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $60,000. The report was filed on April 11.
Original Filing: 301548259.xml
Lobbying Issues
H.R. 4365/S. 2587 - Department of Defense Appropriations for FY 2024; H.R. 2882 - Further Consolidated Appropriations Act, 2024 and unnumbered House and Senate FY25 Department of Defense Appropriations - issues related to defense technology.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Issues related to implementation of the Chips and Science Act of 2022 (P.L. 117-167).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD)
4th Quarter, 2023
In Q4, MCHUGH LEMAY ASSOC., LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $60,000. The report was filed on Jan. 18.
Original Filing: 301527735.xml
Lobbying Issues
H.R. 4365/S. 2587 - Department of Defense Appropriations for FY 2024 - issues related to defense technology.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Issues related to implementation of the Chips and Science Act of 2022 (P.L. 117-167).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD)
3rd Quarter, 2023
In Q3, MCHUGH LEMAY ASSOC., LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $60,000. The report was filed on Oct. 13, 2023.
Original Filing: 301500135.xml
Lobbying Issues
H.R. 4365/S. 2587 - Department of Defense Appropriations for FY 2024 - issues related to defense technology.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Issues related to implementation of the Chips and Science Act of 2022 (P.L. 117-167).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD)
2nd Quarter, 2023
In Q2, MCHUGH LEMAY ASSOC., LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $60,000. The report was filed on July 10, 2023.
Original Filing: 301474105.xml
Lobbying Issues
H.R. 4365 - Department of Defense Appropriations for FY 2024 - issues related to defense technology.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to implementation of the Chips and Science Act of 2022 (P.L. 117-167).
H.R. 2670 - National Defense Authorization Act of 2024 - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2023
In Q1, MCHUGH LEMAY ASSOC., LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $60,000. The report was filed on April 13, 2023.
Original Filing: 301451408.xml
Lobbying Issues
Department of Defense Appropriations for FY 2024 - issues related to defense technology.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to implementation of the Chips and Science Act of 2022 (P.L. 117-167).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2022
In Q4, MCHUGH LEMAY ASSOC., LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $60,000. The report was filed on Jan. 17, 2023.
Original Filing: 301428955.xml
Lobbying Issues
H.R. 8236 - Department of Defense Appropriations for FY 2023 - issues related to defense technology.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Defense - Dept of (DOD)
Lobbying Issues
Issues related to implementation of the Chips and Science Act of 2022 (P.L. 117-167).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD)
3rd Quarter, 2022
In Q3, MCHUGH LEMAY ASSOC., LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $50,000. The report was filed on Oct. 19, 2022.
Original Filing: 301408810.xml
Lobbying Issues
H.R. 8236 - Department of Defense Appropriations for FY 2023 - issues related to defense technology.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to COVID testing - no specific legislation.
Agencies Lobbied
Health & Human Services - Dept of (HHS)
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
2nd Quarter, 2022
In Q2, MCHUGH LEMAY ASSOC., LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $80,000. The report was filed on July 17, 2022.
Original Filing: 301382004.xml
Lobbying Issues
H.R. 7900 - National Defense Authorization Act of 2023 - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 8236 - Department of Defense Appropriations for FY 2023 - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to COVID testing - including H.R. 7900 - National Defense Authorization Act of 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS)
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
1st Quarter, 2022
In Q1, MCHUGH LEMAY ASSOC., LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $100,000. The report was filed on April 13, 2022.
Original Filing: 301345799.xml
Lobbying Issues
H.R. 4350 - National Defense Authorization Act of 2022 / National Defense Authorization Act of 2023 (not yet introduced) - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 4432 - Department of Defense Appropriations for FY 2022 / Department of Defense Appropriations for FY 2023 (not yet introduced) - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to COVID testing - including the National Defense Authorization Act of 2023 (Not yet introduced).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS)
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
4th Quarter, 2021
In Q4, MCHUGH LEMAY ASSOC., LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $100,000. The report was filed on Jan. 16, 2022.
Original Filing: 301323537.xml
Lobbying Issues
H.R. 4350 - National Defense Authorization Act of 2022 - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 4432 - Department of Defense Appropriations for FY 2022 - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to COVID testing - no specific legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS)
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
3rd Quarter, 2021
In Q3, MCHUGH LEMAY ASSOC., LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $40,000. The report was filed on Oct. 14, 2021.
Original Filing: 301299001.xml
Lobbying Issues
H.R. 4350 - National Defense Authorization Act of 2022 - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 4432 - Department of Defense Appropriations for FY 2022 - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to COVID testing - no specific legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS)
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
2nd Quarter, 2021
In Q2, MCHUGH LEMAY ASSOC., LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $40,000. The report was filed on July 14, 2021.
Original Filing: 301275839.xml
Lobbying Issues
National Defense Authorization Act of 2022 - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Department of Defense Appropriations for FY 2022 - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to COVID testing - no specific legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS)
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
1st Quarter, 2021
In Q1, MCHUGH LEMAY ASSOC., LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $60,000. The report was filed on April 16, 2021.
Original Filing: 301254646.xml
Lobbying Issues
National Defense Authorization Act of 2021 - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Department of Defense Appropriations for FY 2022 - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to COVID testing - no specific legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS)
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
4th Quarter, 2020
In Q4, MCHUGH LEMAY ASSOC., LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $60,000. The report was filed on Jan. 15, 2021.
Original Filing: 301232317.xml
Lobbying Issues
S. 4049/H.R. 6395 - National Defense Authorization Act of 2021 - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 7617 - Department of Defense Appropriations for FY 2021 - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to COVID testing - no specific legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS) Office of Science & Technology Policy (OSTP)
Lobbying Issues
Issues related to COVID testing - no specific leghislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS) Office of Science & Technology Policy (OSTP)
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2020
In Q3, MCHUGH LEMAY ASSOC., LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $60,000. The report was filed on Oct. 16, 2020.
Original Filing: 301212050.xml
Lobbying Issues
S. 4049/H.R. 6395 - National Defense Authorization Act of 2021 - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 7617 - Department of Defense Appropriations for FY 2021 - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to COVID testing - no specific legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues related to COVID testing - no specific leghislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS)
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2020
In Q2, MCHUGH LEMAY ASSOC., LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $20,000. The report was filed on July 15, 2020.
Original Filing: 301188788.xml
Lobbying Issues
S. 4049/H.R. 6395 - National Defense Authorization Act of 2021 - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Department of Defense Appropriations for FY 2021 - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2020
In Q1, MCHUGH LEMAY ASSOC., LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $20,000. The report was filed on April 15, 2020.
Original Filing: 301166723.xml
Lobbying Issues
National Defense Authorization Act of 2021 - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Department of Defense Appropriations for FY 2021 - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate